Literature DB >> 16986037

Therapeutic strategies for localized prostate cancer I: surgery, ultrasound, adjuvant and neoadjuvant therapy.

M I Resnick, E D Crawford, M E Gleave, J Lynch, J P Mulhall, K Pummer, G Vallancien.   

Abstract

Over the past decade, because of the introduction and widespread availability of prostate-specific antigen determinations, carcinoma of the prostate that is localized and potentially curable has been diagnosed in an increasing number of men. Advances in surgical management with preservation of the neurovascular bundles, in addition to hormone therapy, have added to the success and improved quality of life of patients undergoing treatment. New forms of treatment (including laparoscopic prostatectomy and high-intensity focused ultrasound) are advances that are continuing to be developed and that may have a significant role in the management of this disease. With further investigation and technologic advancement, it is anticipated that more and more men with localized disease will be identified and cured, with preservation of sexual and urinary function.

Entities:  

Year:  2000        PMID: 16986037      PMCID: PMC1557463     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  38 in total

1.  Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule.

Authors:  D F Paulson; J W Moul; J E Robertson; P J Walther
Journal:  J Urol       Date:  1990-06       Impact factor: 7.450

2.  Laparoscopic radical prostatectomy: the Montsouris experience.

Authors:  B Guillonneau; G Vallancien
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

3.  High-burst-strength, feedback-controlled bipolar vessel sealing.

Authors:  J S Kennedy; P L Stranahan; K D Taylor; J G Chandler
Journal:  Surg Endosc       Date:  1998-06       Impact factor: 4.584

4.  The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels.

Authors:  P H Lange; D J Lightner; E Medini; P K Reddy; R L Vessella
Journal:  J Urol       Date:  1990-10       Impact factor: 7.450

5.  Radiotherapy vs. hormonal therapy for the management of locally recurrent prostate cancer following radical prostatectomy.

Authors:  M S Anscher; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-11       Impact factor: 7.038

6.  Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcN0) prostate cancer from 1976 to 1989: intermediate findings.

Authors:  J A Freeman; G Lieskovsky; D W Cook; Z Petrovich; S Chen; S Groshen; D G Skinner
Journal:  J Urol       Date:  1993-05       Impact factor: 7.450

7.  External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy.

Authors:  G R Ray; M A Bagshaw; F Freiha
Journal:  J Urol       Date:  1984-11       Impact factor: 7.450

8.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.

Authors:  A W Partin; C R Pound; J Q Clemens; J I Epstein; P C Walsh
Journal:  Urol Clin North Am       Date:  1993-11       Impact factor: 2.241

9.  Randomized study of neoadjuvant testicular androgen ablation therapy before radical prostatectomy in men with clinically localized prostate cancer.

Authors:  B L Dalkin; F R Ahmann; R Nagle; C S Johnson
Journal:  J Urol       Date:  1996-04       Impact factor: 7.450

10.  Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.

Authors:  P C Walsh; A W Partin; J I Epstein
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.